Coulter

FDA Lists Beckman Coulter Life Sciences RNA Extraction Kit For Use In EUA-Authorized COVID-19 Test

Retrieved on: 
Thursday, May 28, 2020

Beckman Coulter Life Sciences has remained committed to developing high-performing, scalable reagents for laboratories testing COVID-19 patient swab samples.

Key Points: 
  • Beckman Coulter Life Sciences has remained committed to developing high-performing, scalable reagents for laboratories testing COVID-19 patient swab samples.
  • "RNA extraction is essential today for reliable COVID-19 testing," said Thomas Marshall, Ph.D., Genomics R&D Leader, Beckman Coulter Life Sciences.
  • In March, Beckman Coulter Life Sciences published two demonstrated RNA extraction methods for viral samples.
  • Beckman Coulter Life Sciences is an operating company within Danaher Corporation's (NYSE: DHR) Life Sciences platform.

Beckman Coulter launches DxH 690T mid-volume hematology analyzer, featuring the Early Sepsis Indicator in U.S. market

Retrieved on: 
Monday, May 18, 2020

BREA, Calif., May 18, 2020 /PRNewswire/ -- Beckman Coulter announced today the availability of its DxH 690T hematology analyzer in the U.S.

Key Points: 
  • BREA, Calif., May 18, 2020 /PRNewswire/ -- Beckman Coulter announced today the availability of its DxH 690T hematology analyzer in the U.S.
  • The DxH 690T brings mid-volume laboratories advanced features such as the Early Sepsis Indicator (ESId) available on Beckman Coulter's larger high-volume analyzer, the DxH900.
  • The DxH 690T also supports standardization across hospital networks to a single platformDxH 900 for larger-volume labs and DxH 690T for mid-volume."
  • Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.

Beckman Coulter awarded expanded partnership with BARDA to assess sepsis diagnostic and prediction algorithm with COVID-19 patients

Retrieved on: 
Friday, May 15, 2020

BREA, Calif., May 15, 2020 /PRNewswire/ --Beckman Coulter today announced it was awarded an expanded partnership with BARDA as part of their rapidly expanding COVID-19 medical countermeasure portfolio.

Key Points: 
  • BREA, Calif., May 15, 2020 /PRNewswire/ --Beckman Coulter today announced it was awarded an expanded partnership with BARDA as part of their rapidly expanding COVID-19 medical countermeasure portfolio.
  • The partnership was awarded to Beckman Coulter, in collaboration with Dascena, Inc., for additional advanced research and development toward optimization of a machine-learning based sepsis diagnostic and prediction algorithm to include assessing its use with coronavirus (COVID-19) patients.
  • "Until recently, the majority of sepsis cases have been thought to be caused by bacterial pathogens," said Shamiram R. Feinglass, M.D., MPH, chief medical officer, Beckman Coulter.
  • Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.

Whiteford Continues Richmond Expansion with Prominent Government Contracts Hires

Retrieved on: 
Tuesday, February 18, 2020

Whiteford Taylor & Preston has announced that Thomas A. Coulter and Nicole Hardin Brakstad have joined the firm in Richmond.

Key Points: 
  • Whiteford Taylor & Preston has announced that Thomas A. Coulter and Nicole Hardin Brakstad have joined the firm in Richmond.
  • They have exceptionally deep government contracts experience, and we see immediate synergies for our firm, not only in Richmond but in Washington, D.C., and beyond.
  • With well over 20 years of government contracts experience, Mr. Coulter has a significant concentration in government contracts litigation, including litigation with numerous government departments and agencies, both state and federal, and substantial lead counsel experience in trials involving government contract matters.
  • Vern Inge, Managing Partner of the Richmond office, said, We are really pleased that Tom and Nicole have chosen Whiteford as the right platform for their highly successful government contracts practice.

Beckman Coulter's Access PCT Procalcitonin Assay receives U.S. FDA 510(k) clearance

Retrieved on: 
Tuesday, January 28, 2020

BREA, Calif., Jan. 28, 2020 /PRNewswire/ -- Beckman Coulter, a global leader in clinical diagnostics, todayannounced that its Access PCT assay has received FDA 510(k) clearance and is now available for sale in the United States.

Key Points: 
  • BREA, Calif., Jan. 28, 2020 /PRNewswire/ -- Beckman Coulter, a global leader in clinical diagnostics, todayannounced that its Access PCT assay has received FDA 510(k) clearance and is now available for sale in the United States.
  • The Access PCT assay enables healthcare providers to integrate procalcitonin testing analysis into their routine sepsis workups on core laboratory analyzers, as a primary or reflex test programmed though Beckman Coulter's REMISOL Advance middleware.
  • Access PCT is available for use on Beckman Coulter's Access Family of Immunoassay Systems including the Access 2, UniCel DxI 600 and UniCel DxI 800.
  • For more information regarding the Access PCT assay or Beckman Coulter's full suite of solutions for sepsis diagnosis and management, www.BeckmanCoulter.com/Sepsis .

Covanos Named Platinum Winner At Cleveland Clinic's 2019 Medical Innovation Summit AMP'D Arena Competition

Retrieved on: 
Thursday, October 31, 2019

ATLANTA, Oct. 31, 2019 /PRNewswire/ -- Covanos, Inc., an Atlanta-based private medical technology company, was named the Platinum Winner of the AMP'D Arena Pitch Competition at the 2019 Medical Innovation Summit, organized by Cleveland Clinic and co-sponsored by the Wallace H. Coulter Foundation.

Key Points: 
  • ATLANTA, Oct. 31, 2019 /PRNewswire/ -- Covanos, Inc., an Atlanta-based private medical technology company, was named the Platinum Winner of the AMP'D Arena Pitch Competition at the 2019 Medical Innovation Summit, organized by Cleveland Clinic and co-sponsored by the Wallace H. Coulter Foundation.
  • The competition selects the top company that is "leading the way in best-in-class healthcare technology poised to impact the way we care for patients, caregivers and the community everywhere".
  • "Speaking for the entire Covanos team, we are honored to receive this prestigious award," saidDr.
  • The AMP'D Arena was co-host to the fourth annual Coulter Investment Forum highlighting the most compelling investment opportunities from the national portfolio of Coulter Translational Partner Programs.

Beckman Coulter receives BARDA funding to develop algorithm to aid in the early detection of sepsis*

Retrieved on: 
Tuesday, October 29, 2019

The contract will enable Beckman Coulter, in collaboration with Dascena, Inc, to develop and commercialize a novel machine-learning-based sepsis detection algorithm.

Key Points: 
  • The contract will enable Beckman Coulter, in collaboration with Dascena, Inc, to develop and commercialize a novel machine-learning-based sepsis detection algorithm.
  • "Delays in the detection and treatment of sepsis during its early phases can contribute significantly to adverse outcomes.
  • "We are proud to partner with BARDA and to further our shared mission of advancing healthcare by improving early detection for sepsis patients," said Chris Riley, president of Beckman Coulter Diagnostics.
  • Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.

Mid-size laboratories can now enjoy the same efficiency benefits as large facilities with Beckman Coulter's new hematology analyzer

Retrieved on: 
Monday, October 21, 2019

It also supports standardization across hospital networks to a single platformDxH 900 for larger labs and DxH 690T for medium labs."

Key Points: 
  • It also supports standardization across hospital networks to a single platformDxH 900 for larger labs and DxH 690T for medium labs."
  • The DxH 690T analyzer applies the company's core hematology technologiesthe enhanced Coulter Principle, VCS 360 and DataFusionfor high-resolution analysis of cells in their near native-states.
  • Beckman Coulter offers a unique combination of people, processes and solutions designed to elevate the performance of clinical laboratories and healthcare networks.
  • Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.

Beckman Coulter's DxA 5000 total laboratory automation solution receives U.S. FDA 510(k) clearance

Retrieved on: 
Wednesday, October 9, 2019

BREA, Calif., Oct. 9, 2019 /PRNewswire/ -- Beckman Coulter, a global leader in clinical diagnostics, announced today that the DxA 5000 total laboratory automation solution has received FDA 510(k) clearance and is now available for sale in the United States.

Key Points: 
  • BREA, Calif., Oct. 9, 2019 /PRNewswire/ -- Beckman Coulter, a global leader in clinical diagnostics, announced today that the DxA 5000 total laboratory automation solution has received FDA 510(k) clearance and is now available for sale in the United States.
  • The DxA 5000 significantly reduces the number of manual steps in sample processing, going from 32 steps down to just four.
  • Moreover, the DxA 5000 utilizes Intelligent Routing to bring automated patient-centric workflow to the laboratory.
  • For more information on the DxA 5000 or Beckman Coulter's full suite of automation solutions, please visit BeckmanCoulter.com/DxA .

Beckman Coulter's DxH 520 Hematology Analyzer receives Scientists' Choice Award and Named Best New Clinical Product

Retrieved on: 
Wednesday, August 7, 2019

BREA, Calif., Aug. 7, 2019 /PRNewswire/ --Beckman Coulter, a global leader in clinical diagnostics, announced today that its small, but mighty DxH 520 hematology analyzer received the Scientists' Choice Award for Best New Clinical Laboratory Product of 2018.

Key Points: 
  • BREA, Calif., Aug. 7, 2019 /PRNewswire/ --Beckman Coulter, a global leader in clinical diagnostics, announced today that its small, but mighty DxH 520 hematology analyzer received the Scientists' Choice Award for Best New Clinical Laboratory Product of 2018.
  • SelectScience began the Scientists' Choice Awards in 2007 to enable scientists to voice their opinions on the best new laboratory products in several different categories.
  • Beckman Coulter offers a unique combination of people, processes and solutions designed to elevate the performance of clinical laboratories and healthcare networks.
  • Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.